首页> 外文期刊>Communications in Nonlinear Science and Numerical Simulation >Optimized PID control of propofol and remifentanil coadministration for general anesthesia
【24h】

Optimized PID control of propofol and remifentanil coadministration for general anesthesia

机译:全身麻醉中丙泊酚和瑞芬太尼合用的最佳PID控制

获取原文
获取原文并翻译 | 示例
           

摘要

A closed-loop control system for the control of the depth of hypnosis in anesthesia by using propofol-remifentanil coadministration and the Bispectral Index as feedback signal is proposed. A PID controller is employed together with a fixed ratio between propofol and remifentanil infusions. The ratio allows the anesthesiologist to control the opioid-hypnotic balance during surgery. Optimal tuning rules for the proposed controller are obtained offline by using the particle swarm optimization method and by considering a given dataset of patients and a wide range of infusion ratios that covers a rich set of scenarios that might occur in clinical practice. Finally, a gain scheduling strategy guarantees the optimality of the performance both for the induction and the maintenance phase. A Monte Carlo approach is used to evaluate the robustness of the method with respect to intra-and interpatient variability. (C) 2018 Elsevier B.V. All rights reserved.
机译:提出了一种以丙泊酚-瑞芬太尼共同给药和双谱指数为反馈信号控制麻醉深度的闭环控制系统。 PID控制器与丙泊酚和瑞芬太尼输注之间的固定比率一起使用。该比率使麻醉医师能够在手术过程中控制阿片类药物的催眠平衡。通过使用粒子群优化方法并考虑给定的患者数据集和大范围的输液比率(可涵盖临床实践中可能发生的多种情况),可以离线获得针对所建议控制器的最佳调整规则。最后,增益调度策略可确保在入职和维护阶段的性能都达到最佳。蒙特卡罗方法用于评估该方法相对于患者内和患者间变异性的稳健性。 (C)2018 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号